Assessing the concurrent validity, inter-rater reliability and test-re-test reliability of the Australian Treatment Outcomes Profile (ATOP) in alcohol and opioid treatment populations

- Deacon, Rachel M., Mammen, Kristie, Bruno, Raimondo, Mills, Llewellyn, Dunlop, Adrian, Holmes, Jennifer, Jefferies, Meryem, Hall, Michelle, Shakeshaft, Anthony, Farrell, Michael, Graham, Robert, Lintzeris, Nicholas

Patient-Reported outcomes of treatment of opioid dependence with weekly and monthly subcutaneous depot vs daily sublingual buprenorphine: a randomized clinical trial

- Lintzeris, Nicholas, Dunlop, Adrian J., Peterson, Stefan, Tiberg, Fredrik, Haber, Paul S., Lubman, Dan I., Graham, Robert, Hutchinson, Sarah, Arunogiri, Shalini, Hayes, Victoria, Hjelmström, Peter, Svedberg, Agneta

Tracing the affordances of long-acting injectable depot buprenorphine: A qualitative study of patients’ experiences in Australia

- Barnett, Anthony, Savic, Michael, Lintzeris, Nicholas, Bathish, Ramez, Arunogiri, Shalini, Dunlop, Adrian J., Haber, Paul, Graham, Robert, Hayes, Vicky, Lubman, Dan I.

Assessing the validity of the Australian treatment outcomes profile for telephone administration in drug health treatment populations

- Deacon, Rachel M., Mammen, Kristie, Holmes, Jennifer, Dunlop, Adrian, Bruno, Raimondo, Mills, Llewellyn, Graham, Robert, Lintzeris, Nicholas